Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)

Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)

Abstract Aims Early start and patient profile‐oriented heart failure (HF) management has been recommended. In this post hoc analysis from the SHIFT trial, we analysed the treatment effects of ivabradine in HF patients with systolic blood pressure (SBP) < 110 mmHg, resting heart rate (RHR) ≥ 75 b....

Full description

Bibliographic Details
Main Authors: Amr Abdin, Michel Komajda, Jeffrey S. Borer, Ian Ford, Luigi Tavazzi, Cécile Batailler, Karl Swedberg, Giuseppe M.C. Rosano, Felix Mahfoud, Michael Böhm, the SHIFT Investigators
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:ESC Heart Failure
Subjects:
Heart failure
Ivabradine
Risk indicators
High risk
Heart rate
Online Access:https://doi.org/10.1002/ehf2.14455

Internet

https://doi.org/10.1002/ehf2.14455

Similar Items